|
Market Closed -
Bombay S.E.
06:02:21 2026-08-27 EDT
|
5-day change | 1st Jan Change | ||
| 781.00 INR | +0.13% |
|
+0.75% | -3.72% |
| 08-21 | Mercury Laboratories Limited Announces Executive Changes, Effective August 21, 2026 | CI |
| 07-25 | Mercury Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 840M 8.8M 7.55M 7.07M 6.47M 12.19M 12.23M 83.7M 32.72M 423M 33.02M 32.31M 1.4B | P/E 2024 |
17.7x | P/E 2025 | 31.3x |
|---|---|---|---|---|---|
| Enterprise Value | 879M 9.2M 7.9M 7.4M 6.77M 12.76M 12.79M 87.58M 34.24M 443M 34.55M 33.81M 1.47B | EV / Sales 2024 |
1.29x | EV / Sales 2025 | 1.36x |
| Free-Float |
13.68% | Yield 2024 |
0.42% | Yield 2025 | 0.43% |
| 1 day | +0.13% | ||
| 1 week | +0.75% | ||
| Current month | -1.88% | ||
| 1 month | -2.58% | ||
| 3 months | -4.54% | ||
| 6 months | -3.35% | ||
| Current year | -3.72% |
| 1 week | 756 |  | 800 |
| 1 month | 745 | | 826 |
| Current year | 620.55 | | 928.5 |
| 1 year | 620.55 | | 942.9 |
| 3 years | 620.55 | | 1,303 |
| 5 years | 390 | | 1,303 |
| 10 years | 212 | | 1,303 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 74 | 1982-02-15 | |
Ashish Vasavada
DFI | Director of Finance/CFO | 54 | 2021-10-20 |
Saurabh Mittal
COO | Chief Operating Officer | 41 | 2023-11-07 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 74 | 2015-02-22 | |
| Director/Board Member | 71 | 1982-02-15 | |
Paresh Mistry
BRD | Director/Board Member | 57 | 2017-09-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.13% | +0.75% | -7.43% | -3.63% | 9.81M | |
| -2.33% | +0.37% | +77.88% | +35.69% | 378B | |
| +1.05% | +1.48% | +29.60% | -12.60% | 70.23B | |
| -0.13% | +0.75% | +46.11% | +150.46% | 12.15B | |
| +1.34% | +2.45% | +3.39% | +0.70% | 8.45B | |
| -2.31% | -0.94% | -16.02% | -0.35% | 5.17B | |
| -1.19% | +4.65% | -28.68% | +15.69% | 4.66B | |
| +1.34% | -11.74% | -32.42% | +8.76% | 3.03B | |
| -1.54% | -6.87% | -1.95% | +40.78% | 2.61B | |
| +2.75% | -4.05% | -15.05% | -3.95% | 2.13B | |
| Average | +0.14% | -0.59% | +5.54% | +23.15% | 48.62B | |
| Weighted average by Cap. | +0.12% | +0.48% | +65.27% | +30.08% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 756M 7.91M 6.79M 6.36M 5.82M 10.97M 11M 75.29M 29.43M 381M 29.7M 29.06M 1.26B | 751M 7.86M 6.75M 6.32M 5.79M 10.9M 10.93M 74.83M 29.25M 379M 29.52M 28.89M 1.25B |
| Net income | 56.54M 592K 508K 476K 436K 821K 823K 5.63M 2.2M 28.5M 2.22M 2.17M 94.31M | 31.45M 329K 283K 265K 242K 456K 458K 3.13M 1.22M 15.85M 1.24M 1.21M 52.46M |
| Net Debt | -25.4M -266K -228K -214K -196K -369K -370K -2.53M -989K -12.8M -999K -977K -42.37M | 38.95M 408K 350K 328K 300K 565K 567K 3.88M 1.52M 19.63M 1.53M 1.5M 64.96M |
Employees
503
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-27 | ₹781.00 | +0.13% | 47 |
| 26-08-26 | ₹780.00 | -0.13% | 7 |
| 26-08-24 | ₹781.00 | +2.44% | 7 |
| 26-08-21 | ₹762.40 | -1.15% | 31 |
| 26-08-20 | ₹771.30 | -0.50% | 3 |
- Stock Market
- Stocks
- MERCURYLAB6 Stock
Select your edition
All financial news and data tailored to specific country editions
